Pfizer wins bid to invalidate 2 GSK patents relating to RSV vaccine Ruchika Sharma9 Oct 2024 2:33 PM ISTLondon: Pfizer recently achieved a significant legal victory by winning bid in a London court to invalidate two patents held by GlaxoSmithKline (GSK)...
Alembic Pharma secures USFDA nod for Seizure treatment drug Lamotrigine ER Ruchika Sharma3 Oct 2024 1:33 PM ISTVadodara: Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug Administration (USFDA)...
OPPI appoints Bhushan Akshikar as President Ruchika Sharma27 Sept 2024 12:25 PM ISTMumbai: The Organisation of Pharmaceutical Producers of India (OPPI), which represents the global research-based pharmaceutical companies in...
After positive midstage trial, GSK moves mRNA flu vaccine to late-stage trials MD Bureau Team13 Sept 2024 2:56 PM ISTBritish drugmaker GSK announced on Thursday positive results from a mid-stage trial of its seasonal influenza vaccine programme using the...
GSK announces positive results from phase III trial of Nucala in COPD Ruchika Sharma8 Sept 2024 1:30 PM ISTLondon: GSK plc has announced positive headline results of MATINEE, the phase III clinical trial evaluating Nucala (mepolizumab) a...
GSK Nucala approved in Japan for treatment of adults with chronic rhinosinusitis with nasal polyps Ruchika Sharma3 Sept 2024 4:19 PM ISTGSK plc has announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Nucala (mepolizumab), a monoclonal antibody that...
Bepirovirsen granted SENKU designation in Japan for chronic hepatitis B: GSK Ruchika Sharma3 Sept 2024 9:30 AM ISTLondon: GSK plc has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted SENKU (formerly known as SAKIGAKE)...
Submit details of adverse events reported: CDSCO Panel Tells GSK on Mepolizumab Powder for Solution for Injection Dr. Divya Colin24 Aug 2024 6:00 PM ISTNew Delhi: In line with the Phase IV clinical trial report of the monoclonal antibody Mepolizumab (Brand Name: Nucala 100 mg) presented by the drug...
GSK secures USFDA Breakthrough Therapy Designation for GSK5764227 for extensive stage small cell lung cancer Ruchika Sharma21 Aug 2024 11:30 AM ISTLondon: GSK plc has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for GSK5764227 (GSK’227),...
US FDA expands Jemperli plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer: GSK Ruchika Sharma2 Aug 2024 10:00 AM ISTLondon: GSK plc has announced the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab) in combination with carboplatin and...
Blenrep combinations in multiple myeloma application accepted for review by EMA: GSK Ruchika Sharma20 July 2024 3:30 PM ISTLondon: GSK plc has announced that the European Medicines Agency (EMA) has accepted the marketing authorisation application (MAA) for...
GlaxoSmithKline Pharma appoints Dr Shalini Menon as Executive Vice President - Medical Affairs Ruchika Sharma5 July 2024 4:53 PM ISTMumbai: GlaxoSmithKline Pharmaceuticals Limited has appointed Dr. Shalini Menon as Executive Vice President - Medical Affairs, effective 8th...
